Open access · CC-BY
via OpenAlex
From rapalogs to anti-aging formula
Oncotarget · 2017 · ▲ 85 citations
Deregulated nutrient-sensing
Cellular senescence
Stem-cell exhaustion
Altered intercellular communication
Rapamycin / mTOR inhibition
Metformin
Exercise
Partial reprogramming (OSK)
Human
Abstract
// Mikhail V. Blagosklonny 1 1 Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA Correspondence to: Mikhail V. Blagosklonny, email: // email: // Keywords : lifespan, longevity, rejuvenation, health, diseases Received : February 17, 2017 Accepted : April 30, 2017 Published : May 22, 2017 Abstract Inhibitors of mTOR(definition), including clinically available rapalogs such as rapamycin(definition) (Sirolimus) and Everolimus, are gerosuppressants, which suppress cellular senescence(definition). Rapamycin slows aging and extends life span in a variety of species from worm to mammals. Rapalogs can prevent age-related diseases, including cancer, atherosclerosis, obesity, neurodegeneration and retinopathy and potentially rejuvenate stem cells, immunity and metabolism. Here, I further suggest how rapamycin can be combined with metformin, inhibitors of angiotensin II signaling (Losartan, Lisinopril), statins (simvastatin, atorvastatin), propranolol, aspirin and a PDE5 inhibitor. Rational combinations of these drugs with physical exercise and an anti-aging diet (Koschei formula) can maximize their anti-aging effects and decrease side effects.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/oncotarget.18033
- Canonical
- link ↗
- Fetched
- 2026-06-14 MST
Cite this
APA
Blagosklonny, M.V. (2017). From rapalogs to anti-aging formula. <em>Oncotarget</em>. https://doi.org/10.18632/oncotarget.18033
Vancouver
Blagosklonny MV. From rapalogs to anti-aging formula. Oncotarget. 2017. doi:10.18632/oncotarget.18033.
BibTeX
@article{mikhail2017Fromra,
title = {From rapalogs to anti-aging formula},
author = {Mikhail V. Blagosklonny},
journal = {Oncotarget},
year = {2017},
doi = {10.18632/oncotarget.18033},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oncotarget 2023
Open access · CC-BY
Cancer prevention with rapamycin
Journal of Clinical Investigation 2013
Open access · OA
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Cell Death and Disease 2014
Open access · CC-BY
Koschei the immortal and anti-aging drugs
Oncotarget 2021
Open access · CC-BY
Anti-aging: senolytics or gerostatics (unconventional view)
Aging Cell 2015
Open access · CC-BY
Long live <scp>FOXO</scp> : unraveling the role of <scp>FOXO</scp> proteins in aging and longevity
Bone Research 2025
Open access · CC-BY